The association of NLRP3 and TNFRSF1A polymorphisms with risk of ankylosing spondylitis and treatment efficacy of etanercept. [electronic resource]
- Journal of clinical laboratory analysis Nov 2017
Publication Type: Journal Article
1098-2825
10.1002/jcla.22138 doi
Adolescent Adult Cohort Studies Etanercept--therapeutic use Female Humans Immunosuppressive Agents--therapeutic use Linkage Disequilibrium Male Middle Aged NLR Family, Pyrin Domain-Containing 3 Protein--genetics Polymorphism, Single Nucleotide--genetics Receptors, Tumor Necrosis Factor, Type I--genetics Spondylitis, Ankylosing--drug therapy Young Adult